News - Medical and health professional investment - VC and PE investment business - Shenzhen Efung Investment Management Co. Ltd.

发布时间: 2022 - 08 - 01

Recently, Apexigen, a portfolio company of Efung Capital, and Brookline Capital Acquisition Corp.-a Special Purpose Acquisition Company (SPAC)-entered an official merger process, resulting that Brookline Capital Acquisition Corp. was renamed to Apexigen, Inc. Guided and led by Dr. Xiaodong Yang, president as well as Chief Executive Officer (CEO) of Apexigen company, the firm joined the listing of Nasdaq successfully and presented in stock code “APGN” this evening, August 1st, Beijing time. In July 2018, Efung Capital was one of the players of Apexigen's Series C financing.Headquartere...

浏览次数：533

查看详情>>

发布时间: 2022 - 07 - 25

China's first new crown oral drug has been approved for marketing!

On July 25, 2022, the State Drug Administration proclaimed that, in accordance with the relevant provisions of the Drug Administration Law and specific drug approval procedures, the State Drug Administration conducted emergency review and approved Henan Zhenzhen Biotechnology Co., Ltd. with certain conditions. The registration application for Azvudine tablets to treat the novel coronavirus pneumonia has been approved.This is China's first oral anti-COVID-19 drug with entirely autonomous intellectual property rights.

浏览次数：5606

查看详情>>

发布时间: 2025 - 07 - 24

Efung Capital Selected for Zero2IPO's 2024-2025 China Industry Investment List

On July 24, 2025, Zero2IPO's 2024-2025 China Industry Investment List was grandly released. This list cross-validates from three dimensions—industry, technology, and commerce—using a professional, scientific, rigorous, and quantifiable selection methodology to authentically and reliably reflect market development conditions and landscape.Currently, the world is undergoing profound change driven jointly by industrial revolution and capital power, and the globalization of Chinese industry has entered a new narrative. As disruptive technologies such as AI large models, new energy, high-end ma...

浏览次数：1

查看详情>>